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ABSTRACT
Burkholderia cenocepacia infections in CF patients in-
volve heightened inflammation, fatal sepsis, and high
antibiotic resistance. Proinflammatory IL-1 secretion is
important in airway inflammation and tissue damage.
However, little is known about this pathway in macro-
phages upon B. cenocepacia infection. We report here
that murine macrophages infected with B. cenocepacia
K56-2 produce proinflammatory cytokine IL-1 in a
TLR4 and caspase-1-mediated manner. We also deter-
mined that the OPS (O antigen) of B. cenocepacia LPS
contributes to IL-1 production and pyroptotic cell
death. Furthermore, we showed that the malfunction of
the CFTR channel augmented IL-1 production upon B.
cenocepacia infection of murine macrophages. Taken
together, we identified eukaryotic and bacterial factors
that contribute to inflammation during B. cenocepacia
infection, which may aid in the design of novel ap-
proaches to control pulmonary inflammation. J. Leu-
koc. Biol. 89: 481–488; 2011.
Introduction
Macrophages represent a first-line defense against pathogens;
however, the response of macrophages to invading pathogens
may contribute to the destructive, inflammatory process in the
lungs of CF patients [1]. Nearly 85% of the deaths in CF are a
result of progressive inflammation because of respiratory infec-
tions [2, 3]. Therefore, anti-inflammatory intervention should
assume a larger role in CF management until a cure for CF is
discovered.
One way for macrophages to recognize pathogens is
through recognition by TLRs and NLRs. TLRs activate MAPKs
via the MyD88 and TRIF adaptor molecules. Through these
kinase pathways, TLRs activate transcription factors that regu-
late the expression of various host defense genes, including
IL-8, IL-6, IL-1, and TNF- [4].
NLRs respond to microbial components by initiating the
assembly of the inflammasome and the proteolytic activation
of caspase-1 to generate the active forms of proinflammatory
cytokines IL-1 and IL-18 and pyroptosis [5, 6]. Pyroptosis, or
caspase 1-dependent cell death, is inherently inflammatory
and is triggered by various pathological stimuli, such as stroke,
heart attack, or cancer, and is crucial for controlling microbial
infections [7]. Ultimately, tight regulation of caspase-1 activa-
tion is important to control the magnitude of the innate im-
mune response and protect the host from possible damaging
effects, such as heightened inflammation, which may lead to
fatal sepsis.
Strains of the Bcc and in particular, Burkholderia cenocepacia
and Burkholderia multivorans, have become a serious threat to
CF patients as a result of their ability to cause lung infections
with rapid and severe inflammation, necrotizing pneumonia,
and sometimes fatal septicemia [8]. B. cenocepacia strains are
also capable of patient-to-patient transmission and display resis-
tance to nearly all clinically useful antibiotics [9]. The bacte-
rial determinants associated with poor clinical outcome in CF
patients are not clear. Bcc bacteria are extracellular, opportu-
nistic pathogens, which can also become intracellular in eu-
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karyotic cells such as amoebae, epithelial cells, and human
macrophages [10–14].
LPS is a major component of the surface of Gram-negative
bacteria. LPS consists of lipid A, core OS, and in some bacte-
ria, O-specific polysaccharide or O antigen [15]. Lipid A is
embedded in the outer leaflet of the outer membrane and
accounts for the endotoxic activity of LPS [16]. The core OS
moiety has inner-core and outer-core regions. The inner-core
OS typically consists of one to three Kdo residues linked to the
lipid A and three L-glycero-D-manno-heptose residues linked to
the first Kdo [15]. The outer-core region typically consists of
eight to 12 branched sugars linked to heptose II of the inner
core. The O antigen is the outermost component of the LPS
and consists of a repeating OS that is highly variable in terms
of chemical composition, structure, and antigenicity [17].
In this study, we have used B. cenocepacia mutants carrying
various core OS truncations to explore the roles of LPS com-
ponents and host factors in inflammatory cytokine IL-1 pro-
duction in murine macrophages in response to B. cenocepacia.
We report that the LPS O antigen in this bacterium and host
caspase-1 and TLR4 are important modulators of inflammatory
responses in macrophages.
MATERIALS AND METHODS
Bacterial strains and culture
B. cenocepacia strain K56-2 was isolated from a CF patient. This strain is
from the same ET12 lineage as the prototypic epidemic strain J2315 [18].
SAL1 is a heptoseless mutant of K56-2, which was generated by insertional
mutagenesis [19]. Other isogenic mutants of B. cenocepacia K56-2, namely
XOA3, XOA7, and XOA8 [20], carry various core OS truncations (see Sup-
plemental Fig. 1). The mutant XOA3 has an insertional mutation in the
wbxE gene that encodes a glycosyltransferase involved in O antigen synthe-
sis, resulting in the production of lipid A-core OS and a partial O antigen
unit [21] (Supplemental Fig. 1). This mutation recreates the same LPS
phenotype as observed in strain J2315 [21], whose structure has been re-
ported recently [22]. The mutant XOA7 has an inactivated waaL gene and
therefore, harbors a truncated O antigen [20]. The structure of the core
OS in the XOA8 strain reveals a major truncation as a result of mutation in
the wabO gene, which encodes a putative glycosyltransferase responsible for
the glucosylation of HepI (Supplemental Fig. 1). All bacterial strains were
grown in LB broth at 37°C overnight with high-amplitude shaking.
BMDMs
All animal experiments were performed according to protocols approved
by the Animal Care Use Committee of the Ohio State University College of
Medicine (Columbus, OH, USA). WT C57BL/6, MyD88/, TRIF/,
TLR3/, and TLR4/ mice were purchased from Jackson Laboratory
(Bar Harbor, ME, USA). Caspase-1/ mice were obtained from Dr. Amy
Hise (Case Western Reserve University, Cleveland, OH, USA). F508 mice
were obtained from Case Western Reserve University and housed in the
Ohio State University vivarium. Mice homozygous for the Cftr mutation
were provided with Colyte (Schwarz Pharmaceuticals, Mequon, WI, USA)
in their drinking water and the irradiated diet of Teklad 7960. BMDMs
were isolated from femurs of 6- to 12-week-old mice and were cultured in
IMDM containing 10% heat-inactivated FBS, 20% L cell-conditioned me-
dium, 100 U/ml penicillin, and 100 mg/ml streptomycin at 37°C in a hu-
midified atmosphere containing 5% CO2. After 5 days of incubation, cells
were collected and plated in six-well plates or in 24-well plates in IMDM
containing 10% heat-inactivated FBS [23]. About 95% of the BMDMs ob-
tained possess the CSF-1R, 93–98% proliferate in response to CSF-1, and
90% of cells die on removal of CSF-1 from the serum-containing medium.
This latter observation reflects the absence in these cultures of contaminat-
ing, fibroblast-like cells [24]. Macrophages were infected with B. cenocepacia
K56-2 or corresponding mutants at a MOI of 10.
Immunoblotting
Macrophages were stimulated with B. cenocepacia K56-2, and the culture su-
pernatant was removed. The cells were washed twice with PBS and lysed in
lysis buffer solution (150 mM NaCl, 10 mM Tris, pH 7.4, 5 mM EDTA, 1
mM EGTA, and 0.1% Nonidet P-40), supplemented with 1 protease in-
hibitor mixture (Roche Applied Science, Indianapolis, IN, USA). The cell
lysate was centrifuged for the removal of any insoluble material. The pro-
tein concentration was adjusted to 20 ug. After clarification, samples were
denatured with SDS buffer and boiled for 10 min; proteins were separated
on SDS-15% polyacrylamide gel and transferred to a PVDF membrane
(Bio-Rad Laboratories, Hercules, CA, USA). Membranes were immunoblot-
ted against IL-1 (antibody kindly provided by M. D. Wewers), and pro-
IL-1 protein was detected with secondary anti-rabbit antibody conjugated
to HRP, followed by ECL reagents (Amersham ECL Western blotting detec-
tion reagents, GE Healthcare-Life Sciences, UK).
ELISA
Macrophages were infected with B. cenocepacia K56-2 for 24 h, and the cul-
ture supernatant was collected, centrifuged, and stored at –20°C until as-
sayed for cytokine content. The activity of IL-1, IL-6, and TNF- in the
supernatant was determined by specific sandwich ELISA following the man-
ufacturer’s protocol (R&D Systems, Minneapolis, MN, USA) and as de-
scribed previously [25].
RT-qPCR
Total RNA was extracted from macrophages infected for 24 h with B. ceno-
cepacia K56-2 or the appropriate mutants by the phenol and guanidine iso-
thiocyanate (TRIzol reagent)-chloroform method (Invitrogen Life Technol-
ogies, Carlsbad, CA, USA). One to 2 g RNA was reverse-transcribed into
cDNA by the Taqman MicroRNA RT kit (Applied Biosystems, Foster City,
CA, USA) at 16°C for 30 min, 42°C for 30 min, and 85°C for 5 min. cDNA
(26 ng) was used for qPCR with Power SYBR Green PCR master mix in the
Step One Plus RT-PCR system (Applied Biosystems) at 95°C for 10 min,
95°C for 15 s, and 60°C for 1 min for 40 cycles for IL-1 and mouse
GAPDH. The target gene Ct values were normalized to the Ct values of the
housekeeping gene, GAPDH, and expressed as RCN, as described earlier
[26]. Primer sequences used in the study for mouse IL-1 were 5-CCTGT-
GTTTTCCTCCTTGCCT-3 and 5-GCCTAATGTCCCCTTGAATCAA-3, and
those for mouse GAPDH were 5-GCAAAGTGGAGATTGTTGCCAT-3 and
5-CCTTGACTGTGCCGTTGAATTT-3.
Cell death detection
WT macrophages were infected with B. cenocepacia parent strain K56-2 or
mutants SAL1, XOA3, XOA7, and XOA8 for 24 h. Cell lysates from in-
fected macrophages were prepared and used for in vitro quantification of
apoptosis. Histone-associated DNA fragments were detected using the cell
death detection ELISAplus photometric enzyme immunoassay kit from
Roche Applied Science to the specifications of the manufacturer [25]. Ev-
ery sample was performed in triplicate; mean  sd was calculated for each
sample after subtraction of the blank from each reading. Results are dis-
played as fold increase from the untreated cells.
RESULTS
B. cenocepacia K56-2 induces caspase-1 and IL-1
mRNA in murine macrophages
To understand the role of the inflammasome in macrophages
infected with B. cenocepacia, we quantified mRNA of different
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inflammasome components by RT-qPCR. Primary WT mouse
macrophages infected with B. cenocepacia K56-2 for 4 h were
processed by RT-qPCR for open array analysis (BioTrove, Cam-
bridge, MA, USA). Among different inflammasome compo-
nents, the caspase-1 message was increased sixfold (P0.001;
Fig. 1A), and the IL-1 message was increased 20-fold in re-
sponse to B. cenocepacia when compared with uninfected con-
trols (P0.05; Fig. 1B). Accordingly, protein levels of pro-
IL-1 were increased in macrophages when infected with B.
cenocepacia (Fig. 1F). As activation of the inflammasome is ac-
companied by the release of mature IL-1 into macrophage
culture supernatants, we tested whether WT murine macro-
phages release mature IL-1 in response to B. cenocepacia K56-2
infection. Macrophages were infected at a MOI of 10 for 24 h,
and culture supernatants were examined for the presence of
active IL-1 by ELISA as indicated in Materials and Methods.
Fig. 1C shows that infection with K56-2 induces the release of
high levels of IL-1. Therefore, B. cenocepacia provokes a
strong IL-1 response in murine macrophages.
IL-1 induction and release in B. cenocepacia
K56-2-infected murine macrophages are mainly
MyD88- and partially TLR4-dependent
The induction of the IL-1 message can be TLR-mediated
[27]. Accordingly, to discern the identity of TLR involved in
the innate immune response to B. cenocepacia K56-2, infections
were also carried out in macrophages lacking MyD88 or TRIF,
and then IL-1 production was examined at 24 h postinfec-
tion. MyD88 is an adaptor molecule for most TLRs except
TLR 3, whereas TRIF is an adaptor molecule for TLR3 and -4.
Compared with infected WT macrophages, MyD88/ macro-
phages did not significantly up-regulate the IL-1 message
[eightfold difference (P0.05); Fig. 1B] and only released
negligible amounts of IL-1 (Fig. 1C). Also, infected TRIF/
macrophages showed less up-regulation of the IL-1 message
[3.5-fold difference (P0.05); Fig. 1D] and released 50% less
IL-1 (Fig. 1E). Western blot analysis demonstrated that pro-
IL-1 protein levels were increased in infected WT macro-
phages but reduced in macrophages lacking MyD88 or TRIF
(Fig. 1F). These data demonstrate that TLR3 or TLR4 is re-
quired for induction of IL-1 by B. cenocepacia K56-2.
As MyD88 and TRIF are adaptor molecules for TLR4, we
examined the activation and release of IL-1 in macrophages
lacking TLR4. TLR3/ macrophages were used as a control.
TLR4/ macrophages released less IL-1 into culture super-
natants when infected with K56-2 for 24 h (Fig. 2A). However,
TLR3/ macrophages released levels of IL-1 that were simi-
lar to those of infected WT macrophages (Fig. 2A). The induc-
tion of the IL-1 message was compromised in TLR4/ mac-
rophages compared with WT macrophages (P0.01; Fig. 2B).
IL-1 protein analysis by Western blots showed that pro-IL-1 is
induced in WT macrophages and to a lesser extent, in macro-
phages lacking TLR4 (Fig. 2C). Therefore, the up-regulation and
the expression of pro-IL-1 in response to B. cenocepacia K56-2
involve TLR4.
B. cenocepacia K56-2 O antigen polysaccharide
contributes to IL-1 production and pyroptotic cell
death of infected macrophages
As TLR4 is required for IL-1 production by B. cenocepacia,
and TLR4 interacts with LPS, we examined the effect of B.
cenocepacia mutants lacking different portions of the LPS mole-
cule on IL-1 production (Supplemental Fig. 1). WT macro-
phages were infected with K56-2 and the mutant SAL1. Infec-
tion with the heptoseless LPS strain SAL1 resulted in a nine-
fold reduction (P0.05) in IL-1 release compared with WT
macrophages (Fig. 3A). SAL1 induction of IL-1 message was
also defective (P0.05; Fig. 3B). Yet, SAL1 induced the pro-
duction of IL-6 and TNF- similar to parent strain K56-2 (Fig.
3C and D).
To pinpoint which portion of the LPS molecule is important
for induction of IL-1 production and release, we took advan-
tage of a panel of mutants carrying various LPS truncations
(Supplemental Fig. 1) [21, 28]. The macrophages infected
with XOA3, XOA7, and XOA8 mutants secreted less IL-1
compared with the parent strain K56-2 (Fig. 4A). However,
IL-6 and TNF- production in response to XOA3, XOA7, and
XOA8 was comparable with that of K56-2-infected macro-
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Figure 1. IL-1 is induced by B. cenocepacia
K56-2 and requires host MyD88 and TRIF.
BMDMs from WT (C57BL/6), MyD88/,
and TRIF/ mice were uninfected (UI) or
infected with clinical isolate B. cenocepacia
K56-2, and the cells were lysed in TRIzol.
RNA was extracted and analyzed by RT-qPCR
for caspase-1 (A) and IL-1 (B and D). Mu-
rine BMDMs from WT and MyD88/ (C)
and TRIF/ (E) were uninfected or infected
with B. cenocepacia K56-2 clinical isolate, and
the culture supernatants were assayed for the
release of mature IL-1 (C and E). The re-
sults are expressed as the mean of triplicate
samples  sd, representative of three inde-
pendent experiments. *P  0.05; ***P 
0.001. Samples similar to those described
above were lysed and analyzed by Western
blot for the expression of pro-IL-1 (F).
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phages, except for XOA7, which provoked much less IL-6 pro-
duction than the rest of the mutants (Supplemental Fig. 2A
and B). The XOA3 mutant lacks a portion of the O antigen
while maintaining the rest of the LPS molecule intact (Supple-
mental Fig. 1). This mutation recreates the same LPS pheno-
type as observed in strain J2315 [21], of which the structure
has been reported recently [22]. Taken together, we con-
cluded that B. cenocepacia O antigen is required for IL-1 pro-
duction through host TLR4.
We next examined apoptosis induction in WT macrophages
in response to the parent strain K56-2 and the derived LPS
mutants XOA3, XOA7, and XOA8 [7]. Fig. 4C shows that the
truncation of the O antigen diminished apoptotic cell death
(P0.01). Taken together, our data demonstrate that TLR4
contributes to IL-1 production in response to B. cenocepacia,
however the contribution of another unidentified, MyD88-de-
pendent TLR cannot be excluded.
Caspase-1 is essential for IL-1 production by
macrophages in response to B. cenocepacia K56-2
infection
NLRs respond to microbial components through the activation
of caspase-1 [6], which becomes activated by cleavage to gener-
ate an enzymatically active heterodimer composed of 10 and
20 kDa chains [6, 29]. Upon activation, caspase-1 cleaves pro-
IL-1 and pro-IL-18 to generate biologically active cytokines
[6, 29]. To determine if IL-1 activation in response to B. ceno-
cepacia requires caspase-1, WT macrophages and caspase-1/
macrophages were infected with B. cenocepacia K56-2 for 24 h,
and cytokines were evaluated in cell supernatants (Fig. 5). The
amount of IL-1 produced by K56-2-infected macrophages
lacking caspase-1 was almost undetectable when compared
with WT macrophages (Fig. 5A). IL-6 produced by caspase-
1/ macrophages was similar to that of WT cells (Fig. 5B).
TNF- levels were decreased in macrophages lacking
caspase-1, which could be a secondary effect for the lack of
IL-1 (Fig. 5C). Therefore, caspase-1 is essential for IL-1
production by macrophages during B. cenocepacia infections,
suggesting an involvement of the inflammasome.
The F508 mutation in the CFTR gene increases
IL-1 release in response to B. cenocepacia K56-2
infection
As B. cenocepacia infects mainly CF patients, and a recent study
demonstrated that TLR4 expression is increased on monocytes
and macrophages derived from CF patients [30], we examined
IL-1 release from primary murine macrophages derived from
WT mice and compared them with those derived from mice
harboring a F508 mutation. WT and F508 BMDM were in-
fected with K56-2, and cell supernatants were examined for
cytokine release (Fig. 6). Notably, IL-1 release was increased
significantly in the presence of the F508 mutation (P0.05;
Fig. 6A), as well as IL-6 and TNF- production (P0.001; Fig.
6B and C). These results suggest that the CFTRF508 muta-
tion contributes to an exacerbated, proinflammatory response
by macrophages (Fig. 6B and C).
DISCUSSION
The hallmark of infection in the CF lung is severe inflam-
mation, which destroys the lung tissue [1, 31–33]. Infections
by Bcc bacteria, in particular, B. cenocepacia, can also lead to
necrotizing pneumonia resulting in death [34]. Although
the role of macrophages in CF has been recognized [1, 31,
32, 35], the host receptors and key bacterial determinants
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Figure 2. IL-1 is induced by B. cenocepacia K56-2 and uses host
TLR4. Murine BMDMs from WT and TLR3/ and TLR4/ were
uninfected or infected with B. cenocepacia K56-2 clinical isolate. and
the supernatants were analyzed for the release of mature IL-1 (A).
BMDMs from WT and TLR4/ mice were uninfected or infected
with clinical isolate B. cenocepacia K56-2, and the cells were lysed in
TRIzol. RNA was extracted and analyzed by RT-qPCR for IL-1 (B).
The results are expressed as the mean of triplicate samples  sd,
representative of three independent experiments. **P  0.01;
***P  0.001. Cell lysates from WT, TLR3/, and TLR4/
BMDM were infected with K56-2 and then analyzed by Western
blots for pro-IL-1 expression (C). Blots are representative of more
than three independent experiments.
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associated with the heightened inflammatory state and poor
clinical outcome in CF patients are not well understood.
Several studies showed that purified B. cenocepacia LPS stimu-
lates the respiratory burst response of human neutrophils to B.
cenocepacia infections [36]. B. cenocepacia and B. multivorans ly-
sates or LPS derived from them induce significant proinflam-
matory cytokine production and TNF- production from U937
macrophages compared with LPS from other lung pathogens
including Pseudomonas aeruginosa [36–39]. Using three differ-
ent LPS preparations, Shimomura et al. [40] demonstrated
that highly purified LPS is not recognized by TLR4 and weakly
induces IL-1. On the other hand, Bamford et al. suggested
that highly purified B. cenocepacia LPS is recognized by TLR4
and mediates NF-B activation in human monocytic cell lines
[11]. Another study with purified B. cenocepacia LPS showed
that LPS and lipid A are responsible for cytokine production,
such as IL-6 and TNF- [37, 41–44], whereas the OPS pre-
vents phagocytosis by macrophages and adhesion to epithe-
lial cells [28].
IL-1 is an important inflammatory cytokine associated with
tissue destruction and pyroptosis [7]. To produce IL-1, mac-
rophages need a double stimulation, one through TLR li-
gands, which induce gene transcription, and another through
NLR agonists, which activate caspase-1 via the inflammasome
complex [27]. It is essential to discern the role of IL-1 dur-
ing B. cenocepacia infection, as BAL of infected CF patients
shows high levels of IL-1. With the aid of a panel of B. cenoce-
pacia LPS mutants, we show here that B. cenocepacia O antigen
contributes to the induction of the IL-1 message within in-
fected macrophages, as the truncation of the O antigen poly-
saccharide induces less IL-1 production. It is unlikely that the
decrease in IL-1 is a result of reduced uptake of the organ-
ism, as several studies demonstrated that the internalization of
strains that lack O antigen was unaltered or increased com-
pared with their isogenic smooth parent strain [28, 44]. Con-
currently, similar to previous studies, we also found that a hep-
toseless LPS mutant, lacking outer-core and O antigen, did not
alter the TNF response to B. cenocepacia [44]. Notably, the O
antigen also adds to macrophage death, which explains the
severe damage observed in the lung of B. cenocepacia-infected
patients.
In epithelial cells, TLR5 but not TLR2 or TLR4 regulates B.
cenocepacia-induced lung epithelial inflammatory responses
[45]. Others have reported that TLR4 and TLR5 are potential
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receptors for B. cenocepacia LPS and flagella, respectively, and
bacteria–receptor interactions result in NF-B activation and
IL-8 secretion in epithelial cells [39]. Our data demonstrate
that in macrophages, TLR4 senses B. cenocepacia LPS, leading
to up-regulation of the pro-IL-1 message. IL-1 production
was absent in MyD88/ macrophages yet diminished in
TRIF/ and TLR4/ macrophages. Taken together, our
data demonstrate that TLR4 is a major factor for IL-1 pro-
duction in response to B. cenocepacia, yet another unidentified,
MyD88-dependent TLR is also required. Ultimately, these data
suggest that developing means for the tight regulation of IL-1
and pyroptotic cell death can decrease the tissue damage ob-
served in the lungs of CF patients when infected with B. cenoce-
pacia.
Once up-regulated, IL-1 is then activated and released in a
caspase-1-dependent manner [27]. As caspase-1 activation typi-
cally requires the assembly and activation of the inflam-
masome complex, it is conceivable that an unidentified cytoso-
lic receptor senses B. cenocepacia in the cytosol and brings the
inflammasome components together, leading to caspase-1 acti-
vation that cleaves pro-IL-1 to its active form. Given that in-
tracellular B. cenocepacia remains in the phagocytic vacuole, a
cytosolic activation of inflammasome components would imply
that the bacterial effectors are released from the phagocytic
vacuole through membrane damage of the vacuole or active
secretion mediated by T3SS, T4SS, or T6SS, as we are investi-
gating currently.
It is more evident that CFTR dysfunction is associated
with increased inflammatory responses by means of several
pathways, connected at least in part with the accumulation
of abnormal CFTR protein forms, especially in the case of
the F508 mutation [46, 47]. Notably, monocytes and mac-
rophages derived from CF patients express more TLR4 than
those obtained from non-CF counterparts [30]. Here, we
demonstrate that macrophages harboring the F508 muta-
tion produced exacerbated levels of IL-1 in response to B.
cenocepacia. It is possible that this is a result of increased ex-
pression of TLR4 in macrophages derived from mice har-
boring the F508 mutation. Yet, the exact mechanism of
CFTR regulation of IL-1 secretion remains to be delin-
eated.
In summary, we have found that macrophage activation of
the proinflammatory cytokine IL-1 during B. cenocepacia
infection of macrophages requires TLR4 and caspase-1. This
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inflammatory reaction is in response to B. cenocepacia O an-
tigen. Therefore, several major factors could help bridge
the path to new, anti-inflammatory targets aimed at increas-
ing survival in CF patients with B. cenocepacia infections.
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